Hanson McClain Advisors »

Lexaria Bioscience shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Lexaria Bioscience (LEXX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Lexaria Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Lexaria Bioscience held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexaria Bioscience by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $323 89 3.64
2023-12-31 $111 89 1.26

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)

View all positions for Hanson McClain Advisors

Top funds holding Lexaria Bioscience

Invenomic Capital Management
Geode Capital Management
Vanguard Group
Raymond James Financial Services Advisors
ADAR1 Capital Management
Welch Group
Morgan Stanley
Northern Trust
Citadel Advisors
Wealth Enhancement Advisory Services
XTX Topco
Royal Bank of Canada
Oakworth Capital
Tower Research Capital
Advisor Group Holdings

View all funds holding Lexaria Bioscience